Profusa, Inc. (PFSA)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $0.53
- As of
Kresmion compiles this page from PFSA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Profusa, Inc. (PFSA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-06.
See the full PFSA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PFSA on one page. Preview it with sample data, then open it live with a free account.
Preview the PFSA dossierActive events for PFSA
No recent events on PFSA in the last 180 days.
FREE, NO ACCOUNT
Every event on PFSA, as it fires
New filings, 13F moves and cross asset events on PFSA land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, PFSA
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
PFSA's 10-Q filed Aug 19, 2026 states:
As of June 30, 2026, there continue to be factors which raise substantial doubt about the Company's ability to continue as a going concern within one year from the date the condensed consolidated financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on PFSA
PFSA against its peers
PFSA's operating margin of -27706.0% ranks in the 8th percentile of 17 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-07-31.
| Metric | PFSA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 100000 USD | 2.6M USD | 19 | 17 |
| Revenue YoY | n/a | -9.3% | n/a | 6 |
| Gross margin | n/a | 60.4% | n/a | 15 |
| Operating margin | -27706.0% | -378.2% | 8 | 17 |
| Net margin | -35823.0% | -433.0% | 8 | 17 |
| Return on equity | n/a | -219.4% | n/a | 15 |
Peers (22): FEED, LUDG, NUMD, POAS, ODYY, RBOT, VTAK, BTCY, ESMC, NXL, VYCO, ADGM, NUWE, XAIR, CODX, RMSL, IVF, BJDX, AIDX, BDMD, ICCM, VVOS. Left out: EMED (period gap), FZMD (period gap), CSDX (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-07-31. Every figure is one full fiscal year read from one annual filing (PFSA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in PFSA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on PFSA in the last 180 days.
Upstream: SEC EDGAR filings for PFSA
Kresmion, "Profusa, Inc. (PFSA) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/PFSA. Upstream data: SEC EDGAR filings for PFSA.
Link to this data (HTML):
<a href="https://kresmion.com/research/PFSA">Profusa, Inc. (PFSA) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow PFSA on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to PFSA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.